No Data
No Data
A Quick Look at Today's Ratings for Addus HomeCare(ADUS.US), With a Forecast Between $83 to $147
Analysts Have Conflicting Sentiments on These Healthcare Companies: BioCryst (BCRX), Addus Homecare (ADUS) and Jazz Pharmaceuticals (JAZZ)
Here's What Key Metrics Tell Us About Addus HomeCare (ADUS) Q4 Earnings
William Blair Reaffirms Their Buy Rating on Addus Homecare (ADUS)
ADDUS HOMECARE Earnings Results: $ADUS Reports Quarterly Earnings
Addus HomeCare | 8-K: ADDUS HOMECARE ANNOUNCES FOURTH QUARTER AND YEAR END 2024 FINANCIAL RESULTS